Sign in / Join Now
ETFs & Funds
Seattle Genetics Will Exceed And Immunogen Will Meet Market Expectations $
Add a reply...
Latest StockTalks »
people get SGEN breaking news and analysis by email alert.
Get email alerts on SGEN »
Seattle Genetics, Inc.
Get latest price
From other sites
Seattle Genetics Initiates Phase 1 Trial Of SGN-CD123A For Patients With Relapsed Or Refractory Acute Myeloid Leukemia
at TheStreet (Sep 19, 2016)
Seattle Genetics No Longer On Goldman Sachs' Sell List
at Benzinga (Sep 15, 2016)
Analysts' Actions -- Cognizant, Dick's, Seattle Genetics, VF Corp. and More
at TheStreet (Sep 15, 2016)
15,000 shares bought by Seattle Genetics Director
at Nasdaq.com (Sep 9, 2016)
Here's Why Seattle Genetics' Adcetris Is A $2 Billion Product
at Benzinga (Sep 7, 2016)